Bio Protocol vs Chromia — how do they compare? Bio Protocol trades at Rp513.28 (market cap Rp1,15T, Rp256,3M 24h volume), while Chromia trades at Rp265.91 (market cap Rp258,71M, Rp33,78M 24h volume). The key difference: Bio Protocol is far larger — about 4445.1× Chromia's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 974,8M / 978,1M CHR (100%) for Chromia. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Chromia for 50 Days on average.
| BIO | CHR | |
|---|---|---|
Market Cap | Rp1,15T | Rp258,71M |
Volume (24h) | Rp256,3M | Rp33,78M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 974,8M / 978,1M CHR (100%) |
Typical Hold Time | 16 Days | 50 Days |
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Chromia is a standalone Layer-1 blockchain and EVM compatible Layer-2 enhancement for Binance Smart Chain and Ethereum. It is designed to enhance existing dApps and allow for the creation of next-generation dApps by providing scalability, improved data handling, and customizable fee structures. The blockchain uses a unique architecture called relational blockchain, as well as a custom programming language called Rell.
Read more on CHR →